Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (21-30 of 241) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|September 18, 2008
Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?Vu Nguyen, Koen van Besien
Blood|September 10, 2008
Nonmyeloablative conditioning for relapsed follicular lymphomaKoen van Besien, Parameswaran Hari
Leukemia & Lymphoma|August 4, 2012
Therapeutic drug monitoring: a way to improve long-term immunological balance?Daan Dierickx, Koen van Besien
Current Hematologic Malignancy Reports|February 11, 2015
Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?Hongtao Liu, Koen van Besien
Expert Review of Hematology|November 19, 2010
Autologous transplant for primary mediastinal B-cell lymphomaXavier Poiré, Koen van Besien
Leukemia & Lymphoma|December 26, 2024
Is there an optimal approach to thromboprophylaxis in young adults with ALL during induction phase?Eduarda Grinsztejn, Koen van Besien
Expert Opinion on Biological Therapy|June 28, 2011
Alemtuzumab in allogeneic hematopoetic stem cell transplantationXavier Poiré, Koen van Besien
Leukemia & Lymphoma|December 16, 2014
Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly malignedJavier Segovia, Koen van Besien
Leukemia & Lymphoma|December 28, 2020
Is less more? Viewpoint on empiric vancomycin therapy of fever and neutropenia after allogeneic stem cell transplantationMarkus Plate, Koen van Besien
Leukemia & Lymphoma|June 27, 2019
Tocilizumab, in search for a role in acute GVHDUsama Gergis, Koen van Besien
Pageof 25

Showing results (21-30 of 241) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|September 18, 2008
Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects?Vu Nguyen, Koen van Besien
Blood|September 10, 2008
Nonmyeloablative conditioning for relapsed follicular lymphomaKoen van Besien, Parameswaran Hari
Leukemia & Lymphoma|August 4, 2012
Therapeutic drug monitoring: a way to improve long-term immunological balance?Daan Dierickx, Koen van Besien
Current Hematologic Malignancy Reports|February 11, 2015
Alternative donor transplantation--"mixing and matching": the role of combined cord blood and haplo-identical donor transplantation (haplo-cord SCT) as a treatment strategy for patients lacking standard donors?Hongtao Liu, Koen van Besien
Expert Review of Hematology|November 19, 2010
Autologous transplant for primary mediastinal B-cell lymphomaXavier Poiré, Koen van Besien
Leukemia & Lymphoma|December 26, 2024
Is there an optimal approach to thromboprophylaxis in young adults with ALL during induction phase?Eduarda Grinsztejn, Koen van Besien
Expert Opinion on Biological Therapy|June 28, 2011
Alemtuzumab in allogeneic hematopoetic stem cell transplantationXavier Poiré, Koen van Besien
Leukemia & Lymphoma|December 16, 2014
Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly malignedJavier Segovia, Koen van Besien
Leukemia & Lymphoma|December 28, 2020
Is less more? Viewpoint on empiric vancomycin therapy of fever and neutropenia after allogeneic stem cell transplantationMarkus Plate, Koen van Besien
Leukemia & Lymphoma|June 27, 2019
Tocilizumab, in search for a role in acute GVHDUsama Gergis, Koen van Besien
Pageof 25